Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$11.3M Sell
505,551
-479,284
-49% -$10.7M 0.02% 878
2015
Q4
$27.2M Buy
984,835
+408,983
+71% +$11.3M 0.05% 429
2015
Q3
$14.8M Sell
575,852
-112,911
-16% -$2.91M 0.03% 682
2015
Q2
$17M Buy
688,763
+122,449
+22% +$3.03M 0.03% 701
2015
Q1
$14.3M Buy
566,314
+300,808
+113% +$7.58M 0.03% 728
2014
Q4
$6.25M Buy
265,506
+5,732
+2% +$135K 0.01% 1158
2014
Q3
$5.92M Buy
259,774
+40,899
+19% +$933K 0.01% 1181
2014
Q2
$5.32M Sell
218,875
-96,063
-31% -$2.33M 0.01% 1287
2014
Q1
$6.6M Buy
314,938
+90,803
+41% +$1.9M 0.01% 1130
2013
Q4
$5.25M Sell
224,135
-136,689
-38% -$3.2M 0.01% 1208
2013
Q3
$7.76M Buy
360,824
+67,499
+23% +$1.45M 0.01% 1048
2013
Q2
$5.77M Buy
+293,325
New +$5.77M 0.01% 1165

Other funds holding QGENF

Russell Frank Company's QGENF Position: Q1 2016 in Review

Russell Frank Company reduced its QIAGEN NV (QGENF) stake by 49% in Q1 2016, selling an estimated $10.7M and leaving 505,551 shares worth $11.3M. The position accounts for 0.02% of the portfolio, ranked #878.

Russell Frank Company first reported a position in QGENF in Q2 2013 and has held it in 12 quarters since. The position peaked at $27.2M in Q4 2015. 201 funds tracked by Wall St. Rank hold QGENF as of Q1 2016.

  • Russell Frank Company held 505,551 shares of QIAGEN NV worth $11.3M as of Q1 2016.
  • Russell Frank Company sold 479,284 QIAGEN NV shares in Q1 2016, an estimated $10.7M.
  • QIAGEN NV made up 0.02% of Russell Frank Company's portfolio in Q1 2016, its #878 holding.
  • Russell Frank Company first reported a position in QIAGEN NV in Q2 2013 and has held it in 12 quarters since.
  • Russell Frank Company's QIAGEN NV position peaked at $27.2M in Q4 2015.
  • 201 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.